+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Brotizolam Market by Type (Capsule, Tablet), Application (Anxiety Treatment, Insomnia Treatment), Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967950
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Brotizolam Market grew from USD 329.72 million in 2023 to USD 350.00 million in 2024. It is expected to continue growing at a CAGR of 6.46%, reaching USD 511.05 million by 2030.

It functions by enhancing the action of neurotransmitters in the brain to produce a calming effect, thereby facilitating the onset and maintenance of sleep. The increasing number of individuals suffering from sleep disorders, particularly insomnia, across the globe has accentuated the need for brotizolam. Older adults are more prone to sleep disturbances. The global increase in the elderly population has led to a higher need for hypnotic medications, including brotizolam, to manage sleep disorders effectively. However, complexities in achieving optimum quality and formulation difficulties can hamper the widespread adoption of the medicine. Potential side effects and difficulties in delivering the right dosage, coupled with other performance issues of brotizolam, hinder patient preference for the drug. Continuous research and development activities focusing on improving the efficacy and safety profile of hypnotic drugs provide a positive outlook for brotizolam, incorporating it into newer, more effective treatment regimens. There's an opportunity to explore and develop combination therapies where brotizolam is used alongside other treatments, both pharmacological and non-pharmacological, to provide a comprehensive approach to managing insomnia with potentially enhanced patient outcomes.

Regional Insights

In the Americas region, particularly in the U.S. and Canada, there is considerable opportunity for expanding the brotizolam market, driven by the presence of a robust healthcare infrastructure, expansive insurance policies, and key pharmaceutical companies. APAC's drug development and research landscape is emerging, signifying the potential for progress in the brotizolam market. Research and investment efforts are progressively emphasizing the development of pharmaceuticals, including sleeping aids, that harmonize with local market expectations. APAC's strategic position as a pharmaceutical manufacturing hub has enabled the growth of brotizolam medication. In the EU, the market for brotizolam is characterized by stringent regulatory requirements focusing on consumer safety and product efficacy. The presence of a rapidly aging population accentuates the need for sleeping aids, including brotizolam. In the Middle East and Africa, the market dynamics and consumer behavior vastly depend on the specific country's regulatory environment, economic conditions, and cultural attitudes toward mental health and pharmaceutical interventions. Some regions within these areas are seeing increased investments in healthcare infrastructure and services, potentially opening up new avenues for medications such as brotizolam, subject to regulatory approvals.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Brotizolam Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of seeping disorders and a rapidly aging population
  • Growing awareness about symptoms related to mental health disorders

Market Restraints

  • Formulation complexities and need for high quality control

Market Opportunities

  • Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
  • Supportive government and regulatory approvals for brotizolam

Market Challenges

  • Performance issues associated with the use of brotizolam

Market Segmentation Analysis

  • Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
  • Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Brotizolam Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Brotizolam Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App

SUSMED, Inc. has received approval from the Ministry of Health, Labour and Welfare (MHLW) for its SUSMED Med CBT-i App, an insomnia treatment application. The smartphone-based app is designed to offer cognitive behavioral therapy for insomnia (CBT-I) over a course of nine weeks, showing significant therapeutic benefits for individuals suffering from insomnia. By adhering to the app's guidance, users can see an improvement in their symptoms, while physicians can track their progress through an integrated management system. This approval marks a pivotal step towards the application's market launch, with SUSMED currently working towards securing insurance coverage for the product.

Expanding Access to QUVIVIQ®: Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach

Idorsia Ltd and its U.S. subsidiary have announced a significant development, that CVS would include QUVIVIQ (daridorexant) CIV in its Performance Drug List (PDL), effective immediately. This inclusion marks a pivotal moment, as it significantly broadens access to QUVIVIQ, a modern prescription insomnia treatment, by encompassing an audience of around 20 million people enrolled under CVS's plan. With this move, QUVIVIQ secures coverage by two of the United States' major insurance providers, Express Scripts and CVS, in addition to various regional plans and TRICARE, the dedicated healthcare program for U.S. military members, veterans, and their families.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Brotizolam Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Brotizolam Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Boehringer Ingelheim International GmbH., Choseido Pharmaceutical Co., Ltd., Daiko Pharmaceutical Co.,Ltd., Delphis Pharmaceutical, Kyowa Pharmaceutical Industry Co.,Ltd., Medilux Laboratories Pvt. Ltd., Merck KGaA, Mylan N.V., Nichi-Iko Pharmaceutical Co.,Ltd., Nipro Corp., Nissin Pharmaceutical Co.,Ltd., Ohara Pharmaceutical Co.,Ltd., Sannova Analytical LLC, Tatsumi Kagaku Co.,Ltd., Teva Takeda Pharma Ltd., and Yoshindo Inc..

Market Segmentation & Coverage

This research report categorizes the Brotizolam Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Capsule
  • Tablet

Application

  • Anxiety Treatment
  • Insomnia Treatment

Distribution

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of seeping disorders and a rapidly aging population
5.1.1.2. Growing awareness about symptoms related to mental health disorders
5.1.2. Restraints
5.1.2.1. Formulation complexities and need for high quality control
5.1.3. Opportunities
5.1.3.1. Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
5.1.3.2. Supportive government and regulatory approvals for brotizolam
5.1.4. Challenges
5.1.4.1. Performance issues associated with the use of brotizolam
5.2. Market Segmentation Analysis
5.2.1. Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
5.2.2. Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Brotizolam Market, by Type
6.1. Introduction
6.2. Capsule
6.3. Tablet
7. Brotizolam Market, by Application
7.1. Introduction
7.2. Anxiety Treatment
7.3. Insomnia Treatment
8. Brotizolam Market, by Distribution
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Brotizolam Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Brotizolam Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Brotizolam Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App
12.3.2. Expanding Access to QUVIVIQ®: Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. BROTIZOLAM MARKET RESEARCH PROCESS
FIGURE 2. BROTIZOLAM MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BROTIZOLAM MARKET DYNAMICS
FIGURE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BROTIZOLAM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BROTIZOLAM MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 47. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 52. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 53. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 81. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 86. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 87. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 92. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 99. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 135. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 155. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 161. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 167. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 173. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 179. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 191. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 196. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 209. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 215. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 220. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 221. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 226. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 245. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 263. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 281. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 282. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Limited
  • Boehringer Ingelheim International GmbH.
  • Choseido Pharmaceutical Co., Ltd.
  • Daiko Pharmaceutical Co.,Ltd.
  • Delphis Pharmaceutical
  • Kyowa Pharmaceutical Industry Co.,Ltd.
  • Medilux Laboratories Pvt. Ltd.
  • Merck KGaA
  • Mylan N.V.
  • Nichi-Iko Pharmaceutical Co.,Ltd.
  • Nipro Corp.
  • Nissin Pharmaceutical Co.,Ltd.
  • Ohara Pharmaceutical Co.,Ltd.
  • Sannova Analytical LLC
  • Tatsumi Kagaku Co.,Ltd.
  • Teva Takeda Pharma Ltd.
  • Yoshindo Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 350 Million
Forecasted Market Value ( USD ) by 2030 $ 511.05 Million
Compound Annual Growth Rate6.4%
Regions CoveredGlobal

Related Topics

Related Reports

Brotizolam (CAS 57801-81-7) Global Market Research Report 2024 - Product Image

Brotizolam (CAS 57801-81-7) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Forecast 2024-2030 - Product Image

Global Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Global Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Forecast 2024-2030 - Product Image

Global Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Global Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report by Drug Type (Stimulants, Non-stimulants), Demographics (Children, Adults), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report by Drug Type (Stimulants, Non-stimulants), Demographics (Children, Adults), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 110 Pages
  • Global
From
Global Postpartum Depression Drugs Market Size, Share & Trends Analysis Report by Type (Postpartum Blues, Anxiety, PTSD), Treatment (Pharmacotherapy, Hormonal Therapy), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Postpartum Depression Drugs Market Size, Share & Trends Analysis Report by Type (Postpartum Blues, Anxiety, PTSD), Treatment (Pharmacotherapy, Hormonal Therapy), Route of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From

About the Brotizolam Market

Brotizolam is a benzodiazepine drug used to treat mental disorders such as anxiety, panic attacks, and insomnia. It is a short-acting drug, meaning it has a rapid onset of action and a short duration of effect. It is commonly prescribed for short-term relief of symptoms, and is not recommended for long-term use due to its potential for dependence and abuse. Brotizolam is available in tablet form and is usually taken orally. Brotizolam is a widely used drug in the treatment of mental disorders, and is often prescribed in combination with other medications. It is generally considered to be a safe and effective treatment for anxiety and insomnia, although it can cause side effects such as drowsiness, dizziness, and confusion. The market for Brotizolam is highly competitive, with many companies offering the drug in various forms. Some of the major companies in the market include Pfizer, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.